• Certified Lab Equipment & Reagents
  • Fast Dispatch on In-Stock Items
  • Expert Scientific Support

Product details

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL

Catalog number BNC042701-500

Price for BNC042701-500

Sign In for Pricing

Size / count 1x 500 µL

About this product

RAD51 is one of the key factors of DNA repair by homologous recombination and has been shown to have anti-apoptotic activity in tumor cells. RAD51 protein interacts with a variety of tumor suppressor proteins including p53, BRCA1 and BRCA2. Elevated expression of RAD51 enhances radio-resistance of human tumor cells. Overexpression of RAD51 protein in tumor cells renders them resistant against cytotoxic drugs like Cisplatin. RAD51 interacts with BRCA1 and BRCA2 to influence subcellular localization and cellular response to DNA damage. BRCA2 inactivation may be a key event leading to genomic instability and tumorigenesis from deregulation of RAD51. High-level expression of RAD51 has been observed in a variety of human malignancies. RAD51 overexpression correlates with histological grading of the tumor in invasive ductal mammary carcinoma. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number
BNC042701-500
Size / count
1x 500 µL
Dry ice
No
Hazardous
No
Discontinued
No
CAS Number
9007-83-4
Synonyms
RCA1/BRCA2 containing complex; subunit 5; BRCC5; DNA repair protein RAD51; FANCR; HsT16930; MRMV2; RAD51; RAD51 recombinase; RAD51A; RECA; RecA like protein; Recombination protein A
UNSPSC
41116161
UNSPSC Description
Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name
RAD51
Gene ID
5888
NCBI Gene ID
631709
UniProt
Q06609
Swiss Prot
Q06609
Host
Mouse
Species Reactivity
Human
Reactivity
RAD51
Immunogen
Recombinant fragment of human RAD51 protein (around aa 1-134) (exact sequence is proprietary)
Target Antigen
RAD51
Clonality
Monoclonal
Clone
RAD51/2701
Type
Primary
Source
Animal
Origin
Animal
Applications
Flow, intracellular (verified) |WB (verified)
Positive Control
K562, HeLa or MCF-7 cells. Colon or breast Carcinoma.
Stability
2 years
Concentration
0.1 mg/mL
Buffer
PBS, 0.1% BSA, 0.05% azide
Molecular Weight
37 kDa
Shipping Conditions
RT (ND)
Storage Conditions
Stable at room temperature or 37°C (98°F) for 7 days.
Notes
Protect from light
Shelf Life
Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment
IgG2b, kappa
Species
Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification
0.05% sodium azide (CAS 26628-22-8)
Conjugate
CF405S

Frequently Asked Questions

What is the catalog number for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL?

The catalog number for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL is BNC042701-500.

What sizes are available for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL?

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.

Is RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL in stock?

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL?

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL?

Estimated delivery time for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL?

The safety data sheet for RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF405S conjugate, 0.1mg/mL used for?

RAD51 is one of the key factors of DNA repair by homologous recombination and has been shown to have anti-apoptotic activity in tumor cells. RAD51 protein interacts with a variety of tumor suppressor proteins including p53, BRCA1 and BRCA2. Elevated expression of RAD51 enhances radio-resistance of h

Is this product classed as hazardous or restricted for shipping?

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Can you help me confirm if this product is right for my specific experiment?

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

What is the purity of this recombinant protein?

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

You Might Also Like
CD81 / TAPA-1 (1.3.3.22), CF647 conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC470391-100
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC740977-500
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF594 conjugate, 0.1mg/mL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF594 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC940679-500
ACTH (Adrenocorticotrophic Hormone) (AH26), CF740 conjugate, 0.1mg/mL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF740 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC740026-500
CD3e (B-B12), CF640R conjugate, 0.1mg/mL
CD3e (B-B12), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC401052-100
FOXP3 (3G3), CF488A conjugate, 0.1mg/mL
FOXP3 (3G3), CF488A conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC880645-100
CD1a (O10 + C1A/711), CF647 conjugate, 0.1mg/mL
CD1a (O10 + C1A/711), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC470717-500
WT1 (Wilm's Tumor 1) (WT1/857), CF405S conjugate, 0.1mg/mL
WT1 (Wilm's Tumor 1) (WT1/857), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040857-100